Literature DB >> 32787765

Neuroprotection of Rotenone-Induced Parkinsonism by Ursolic Acid in PD Mouse Model.

Walia Zahra1, Sachchida Nand Rai2, Hareram Birla1, Saumitra Sen Singh1, Aaina Singh Rathore1, Hagera Dilnashin1, Richa Singh1, Chetan Keswani1, Rakesh K Singh1, Surya Pratap Singh1.   

Abstract

BACKGROUND: Parkinson's Disease (PD) is characterized by both motor and non-motor symptoms. The presynaptic neuronal protein, α-Synuclein, plays a pivotal role in PD pathogenesis and is associated with both genetic and sporadic origin of the disease. Ursolic Acid (UA) is a well-known bioactive compound found in various medicinal plants, widely studied for its anti-inflammatory and antioxidant activities.
OBJECTIVE: In this research article, the neuroprotective potential of UA has been further explored in the Rotenone-induced mouse model of PD.
METHODS: To investigate our hypothesis, we have divided mice into 4 different groups, control, drug only control, Rotenone-intoxicated group, and Rotenone-intoxicated mice treated with UA. After the completion of dosing, behavioral parameters were estimated. Then mice from each group were sacrificed and the brains were isolated. Further, the biochemical tests were assayed to check the balance between the oxidative stress and endogenous anti-oxidants; and TH (Tyrosine Hydroxylase), α-Synuclein, Akt (Serine-threonine protein kinase), ERK (Extracellular signal-regulated kinase) and inflammatory parameters like Nuclear Factor-κB (NF-κB) and Tumor Necrosis Factor- α (TNF-α) were assessed using Immunohistochemistry (IHC). Western blotting was also done to check the expressions of TH and α-Synuclein. Moreover, the expression levels of PD related genes like α-Synuclein, β-Synuclein, Interleukin-1β (IL-1β), and Interleukin-10 (IL-10) were assessed by using Real-time PCR.
RESULTS: The results obtained in our study suggested that UA significantly reduced the overexpression of α-Synuclein and regulated the phosphorylation of survival-related kinases (Akt and ERK) apart from alleviating the behavioral abnormalities and protecting the dopaminergic neurons from oxidative stress and neuroinflammation.
CONCLUSION: Thus, our study shows the neuroprotective potential of UA, which can further be explored for possible clinical intervention. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Parkinson`s disease; neuroinflammation; oxidative stress; rotenone; ursolic acid; α-synuclein

Year:  2020        PMID: 32787765     DOI: 10.2174/1871527319666200812224457

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  13 in total

Review 1.  Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases.

Authors:  Walia Zahra; Hareram Birla; Saumitra Sen Singh; Aaina Singh Rathore; Hagera Dilnashin; Richa Singh; Priyanka Kumari Keshri; Priyanka Gautam; Surya Pratap Singh
Journal:  Neurochem Res       Date:  2022-04-05       Impact factor: 3.996

2.  Ursolic acid enhances autophagic clearance and ameliorates motor and non-motor symptoms in Parkinson's disease mice model.

Authors:  Yeojin Bang; Yoonjung Kwon; Mihyang Kim; Soung Hee Moon; Kiwon Jung; Hyun Jin Choi
Journal:  Acta Pharmacol Sin       Date:  2022-09-22       Impact factor: 7.169

3.  Association Between Rheumatoid Arthritis and Risk of Parkinson's Disease: A Meta-Analysis and Systematic Review.

Authors:  Dongxiu Li; Xia Hong; Tingyu Chen
Journal:  Front Neurol       Date:  2022-05-11       Impact factor: 4.086

Review 4.  Mucuna pruriens in Parkinson's and in some other diseases: recent advancement and future prospective.

Authors:  Sachchida Nand Rai; Vivek K Chaturvedi; Payal Singh; Brijesh Kumar Singh; M P Singh
Journal:  3 Biotech       Date:  2020-11-10       Impact factor: 2.406

5.  Ferritinophagy-Mediated Ferroptosis Involved in Paraquat-Induced Neurotoxicity of Dopaminergic Neurons: Implication for Neurotoxicity in PD.

Authors:  Yong Zuo; Jinhong Xie; Xincheng Li; Yan Li; Anand Thirupathi; Jianhua Zhang; Peng Yu; Guofen Gao; Yanzhong Chang; Zhenhua Shi
Journal:  Oxid Med Cell Longev       Date:  2021-07-26       Impact factor: 6.543

6.  Fibroblast Growth Factor 21 Modulates Microglial Polarization That Attenuates Neurodegeneration in Mice and Cellular Models of Parkinson's Disease.

Authors:  Changwei Yang; Wuqiong Wang; Pengxi Deng; Chen Li; Liangcai Zhao; Hongchang Gao
Journal:  Front Aging Neurosci       Date:  2021-12-22       Impact factor: 5.750

7.  UNC5C Receptor Proteolytic Cleavage by Active AEP Promotes Dopaminergic Neuronal Degeneration in Parkinson's Disease.

Authors:  Guiqin Chen; Eun Hee Ahn; Seong Su Kang; Yiyuan Xia; Xia Liu; Zhaohui Zhang; Keqiang Ye
Journal:  Adv Sci (Weinh)       Date:  2022-01-12       Impact factor: 16.806

Review 8.  Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders.

Authors:  Jana Ponce; Arzu Ulu; Corrine Hanson; Erin Cameron-Smith; John Bertoni; Jenna Wuebker; Alfred Fisher; Ka-Chun Siu; Vivien Marmelat; Jiri Adamec; Danish Bhatti
Journal:  Front Aging Neurosci       Date:  2022-02-17       Impact factor: 5.750

Review 9.  Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.

Authors:  Sachchida Nand Rai; Neeraj Tiwari; Payal Singh; Anurag Kumar Singh; Divya Mishra; Mohd Imran; Snigdha Singh; Etrat Hooshmandi; Emanuel Vamanu; Santosh K Singh; Mohan P Singh
Journal:  Oxid Med Cell Longev       Date:  2022-08-31       Impact factor: 7.310

Review 10.  Genetic Imaging of Neuroinflammation in Parkinson's Disease: Recent Advancements.

Authors:  Longping Yao; Jiayu Wu; Sumeyye Koc; Guohui Lu
Journal:  Front Cell Dev Biol       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.